Cargando…
Phenotypically Dormant and Immature Leukaemia Cells Display Increased Ribosomal Protein S6 Phosphorylation
Mechanistic/mammalian target of rapamycin (mTOR) activity drives a number of key metabolic processes including growth and protein synthesis. Inhibition of the mTOR pathway promotes cellular dormancy. Since cells from patients with acute myeloid leukaemia (AML) can be phenotypically dormant (quiescen...
Autores principales: | Pallis, Monica, Harvey, Tamsin, Russell, Nigel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795744/ https://www.ncbi.nlm.nih.gov/pubmed/26985829 http://dx.doi.org/10.1371/journal.pone.0151480 |
Ejemplares similares
-
Efficacy of RNA polymerase II inhibitors in targeting dormant leukaemia cells
por: Pallis, Monica, et al.
Publicado: (2013) -
TORC1 phosphorylates and inhibits the ribosome preservation factor Stm1 to activate dormant ribosomes
por: Shetty, Sunil, et al.
Publicado: (2023) -
Striatal Cholinergic Interneurons Display Activity-Related Phosphorylation of Ribosomal Protein S6
por: Bertran-Gonzalez, Jesus, et al.
Publicado: (2012) -
P-glycoprotein and breast cancer resistance protein in acute myeloid leukaemia cells treated with the Aurora-B Kinase Inhibitor barasertib-hQPA
por: Grundy, Martin, et al.
Publicado: (2011) -
Early changes in rpS6 phosphorylation and BH3 profiling predict response to chemotherapy in AML cells
por: Grundy, Martin, et al.
Publicado: (2018)